DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cancidas (Caspofungin) - Overdose - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Overdose (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) where reactions include overdose. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-07

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Other drugs received by patient possibly interacting with the suspect drug:
Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin HCL
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Other drugs received by patient: Colistin; Gentamicin; Neupogen



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin HCL
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Colistin; Neupogen; Gentamicin



Possible Cancidas side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient:

Reactions: Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, tiw
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 2250 mg, qd
    Start date: 2012-05-01
    End date: 2012-05-01

Vancomycin
    Dosage: 2000 mg, qd
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22
    End date: 2012-05-01

Vancomycin
    Dosage: 1800 mg, qd
    Start date: 2012-05-01
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2012-05-26
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Neupogen



Possible Cancidas side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient:

Reactions: Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, tiw
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 2250 mg, qd
    Start date: 2012-05-01
    End date: 2012-05-01

Vancomycin
    Dosage: 1800 mg, qd
    Start date: 2012-05-01
    End date: 2012-06-03

Vancomycin
    Dosage: 1000 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22
    End date: 2012-05-01

Vfend
    Dosage: 200 mg, bid
    Start date: 2012-05-14
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Neupogen



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Other drugs received by patient: Neupogen; Colistin; Gentamicin



Possible Cancidas side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-27

Patient: 54 year old male, weighing 157.0 kg (345.4 pounds)

Reactions: Rhabdomyolysis, Overdose, Blood Creatine Phosphokinase Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cancidas
    Indication: Pneumonia Fungal
    Start date: 2011-02-27
    End date: 2011-02-27

Cancidas
    Start date: 2011-03-04
    End date: 2011-03-04



Possible Cancidas side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-22

Patient: 54 year old male, weighing 157.0 kg (345.4 pounds)

Reactions: Overdose, Rhabdomyolysis, Blood Creatine Phosphokinase Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cancidas
    Start date: 2011-03-04
    End date: 2011-03-04

Cancidas
    Indication: Pneumonia Fungal
    Start date: 2011-02-27
    End date: 2011-02-27



Possible Cancidas side effects in 16 year old female

Reported by a pharmacist from Canada on 2011-12-20

Patient: 16 year old female

Reactions: Overdose, Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-11-29

Patient: 54 year old male, weighing 157.0 kg (345.4 pounds)

Reactions: Overdose, Rhabdomyolysis, Blood Creatine Phosphokinase Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cancidas

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017